Table 2.

Prescriptions for osteoporosis medicines for patients with recorded diagnoses of osteoporosis 2012–17

	Number of patients (n = 25,188)	%
Any osteoporosis medicine	19,268	76.5%
Bisphosphonatea	11,684	46.4%
Denosumab	11,762	46.7%
Otherb	2673	10.6%
No record of osteoporosis medicine	5920	23.5%

^aBisphosphonate includes alendronic acid, clodronic acid, ibandronic acid, pamidronic acid, risedronic acid, zoledronic acid, etidronic acid, tiludronic acid (either singly or in combination)

^bOther includes strontium ranelate, tibolone, raloxifene, and teriparatide